首页 远藤国际制药(usENDP)-基本信息

远藤国际制药(usENDP)-基本信息

日报更新时间:

周报更新时间:04-11 03:39

行情信息

今开价:6.24

最高价:6.32

成交量:4140876.0

昨收价:6.2

最低价:6.02

最新价:6.17

行情图标
概要信息

中文名称:远藤国际制药


英文名称:Endo International PLC


行业:医疗


简介:Endo International plc是一家私营有限责任公司,于2013年10月31日在爱尔兰注册成立


电话:353-1-2682000,1-484-2160000


最新量化综合结论
百科信息
  • 相关网站
  • 百科
  • 员工交易记录
  • 持股信息
  • 领导人信息

远藤国际公司Endo International plc,ENDP通过其下属公司生产与销售彷制药、非处方药以及医疗设备仪器,公司总部位于爱尔兰的都柏林,美国总部在宾夕法尼亚州Malvern。远藤制药通过4个部门来运作公司:美国品牌医药,美国仿制药药品,医疗器械和设备部门以及国际制药。 美国品牌医药部门:提供各种品牌处方产品,包括:泌尿外科、内分泌和肿瘤科等的止痛药,如:Lidoderm, Opana ER, Voltaren Gel, Percocet, Frova, Fortesta Gel, Supprelin LA, Valstar, Vantas, Sumavel DosePro, Aveed和Natesto。 美国仿制药药品分部:提供泌尿外科,中枢神经系统疾病,免疫抑制,肿瘤科,妇女保健,高血压的止痛药产品。 医疗器械和设备部门:提供了包括AMS800及AMS700 MS系列人工尿道括约肌,MONARC筋膜吊床产品,提升前后盆底修复系统,以及男性和女性的骨盆健康的XPS绿光激光系统的各种医疗设备。 国际制药部门:提供Dexedrine,Tridural,Metadol,TRANDATE,Pennsaid和B计划产品的治疗领域,包括注意缺陷多动障碍,疼痛,泌尿和过敏。远藤国际直接销售其品牌的药品和仿制药给各大连锁药房、药店、医院、政府机构和医生。

交易日期 交易人 职位 类型 交易份额 价格
2019-06-16 Kimmel (Roger H) Director Sell 10000 3.93
2019-06-16 Kimmel (Roger H) Director Sell 24951 3.93
2019-06-11 Kimmel (Roger H) Director Sell 25829 4.46
2019-06-11 Kimmel (Roger H) Director Buy 53812 --
2019-06-11 Mansukani (Sharad S M.D.) Director Sell 25829 4.46
2019-06-11 Hyatt (Michael) Director Sell 25829 4.46
2019-06-11 Hyatt (Michael) Director Buy 53812 --
2019-06-11 Hutson (Nancy J) Director Buy 53812 --
2019-06-11 Hutson (Nancy J) Director Sell 25829 4.46
2019-06-11 Montague (William P) Director Sell 25829 4.46
2019-06-11 Montague (William P) Director Buy 53812 --
2019-06-11 Cooke (Shane M) Director Buy 53812 --
2019-06-11 Cooke (Shane M) Director Sell 27982 4.46
2019-06-11 Mansukani (Sharad S M.D.) Director Buy 53812 --
2019-05-25 Nichol (Carrie Ann) Officer Sell 237 6.02
2019-05-15 Coleman (Blaise) Chief Financial Officer Sell 1158 6.69
2019-04-28 Maletta (Matthew Joseph) Officer Sell 389 7.67
2019-04-01 Nichol (Carrie Ann) Officer Sell 2235 8.10
2019-04-01 Maletta (Matthew Joseph) Officer Sell 21142 8.10
2019-04-01 Barry (Patrick A) Officer Sell 10508 8.10
2019-04-01 Coughlin (Terrance John) Chief Operating Officer Sell 37393 8.10
2019-04-01 Coleman (Blaise) Chief Financial Officer Sell 23674 8.10
2019-04-01 Campanelli (Paul V) Chief Executive Officer Sell 146400 8.10
2019-04-01 Pera Antonio R Officer Sell 11669 8.10
2019-02-22 Coughlin (Terrance John) Chief Operating Officer Sell 314 10.51

机构持股
持有者 持有份额 持股比例 份额变化 变化率 报告日期
Geode Capital Management, LLC 2666043 1.18% -2237007 -45.62% 2019-03-31
Paulson & Company Inc 8626900 3.81% -- -- 2019-03-31
Glenview Capital Management LLC 8662136 3.83% 4183800 93.42% 2019-03-31
Miller Value Partners, LLC 9053060 4.00% 101575 1.13% 2019-03-31
Renaissance Technologies Corp 10747860 4.75% -956311 -8.17% 2019-03-31
TPG Group Holdings (SBS) Advisors Inc 22152136 9.79% -- -- 2019-03-31
Vanguard Group Inc 28340634 12.53% 2696259 10.51% 2019-03-31
BlackRock Fund Advisors 28684831 12.67% -14408599 -33.44% 2019-07-31
BlackRock Inc 34613753 15.30% -32164 -0.09% 2019-03-31
State Street Corporation 6871534 3.04% -423436 -5.80% 2019-03-31
Orbimed Advisors, LLC 6165464 2.73% 6165464 -- 2019-03-31
Vanguard Investments Australia Ltd 5753218 2.54% -399 -0.01% 2019-07-31
Dimensional Fund Advisors, Inc. 4878048 2.16% -1343362 -21.59% 2019-03-31
Northern Trust Investments Inc 4675045 2.07% -159895 -3.31% 2019-07-31
Invesco Capital Management LLC 3760310 1.66% -258516 -6.43% 2019-07-31
Morgan Stanley - Brokerage Accounts 3642333 1.61% -1324630 -26.67% 2019-03-31
Northern Trust Corp 3542544 1.57% -39015 -1.09% 2019-03-31
Northern Trust Investments N A 3542544 1.57% -39015 -1.09% 2019-03-31
SSGA Funds Management Inc 3169081 1.40% -1005483 -24.09% 2019-07-31
Dimensional Fund Advisors LP 2817563 1.24% -418515 -12.93% 2019-07-31
Amvescap Plc. 4363628 1.93% -13737 -0.31% 2018-12-31
BlackRock Asset Management Canada Ltd 28821856 12.74% -100858 -0.35% 2019-05-31
D. E. Shaw & Co LP 3340566 1.48% -1083469 -24.49% 2018-12-31
Millennium Management LLC 3068467 1.37% 589387 23.77% 2018-12-31
Teachers Advisors LLC 2936050 1.31% 2491375 560.27% 2018-09-30
Goldman Sachs Group Inc 3853507 1.72% -351436 -8.36% 2018-09-30
Citigroup Inc 4743923 2.11% -718133 -13.15% 2018-09-30
Morgan Stanley & Co Inc 5020889 2.24% 97752 1.99% 2018-06-30
BlackRock Institutional Trust Company NA 6330332 2.82% -1041722 -14.13% 2018-06-30
Fidelity Management & Research Company 6835263 3.05% 754545 12.41% 2018-11-30
TPG Capital LP 22152136 9.87% -- -- 2018-09-30
LMM LLC 9694740 4.33% -51590 -0.53% 2018-06-30
State Street Corp 6780544 3.03% -529819 -7.25% 2018-06-30
Invesco PowerShares Capital Mgmt LLC 3948604 1.76% 1307313 49.50% 2018-06-30
Goldman, Sachs & Co. 3677057 1.64% -237383 -6.06% 2018-06-30
Connor Clark & Lunn Inv Mgmt Ltd 3266901 1.46% -1740634 -34.76% 2018-06-30
Edmond de Rothschild Asset Management (France) 2200000 0.98% -- -- 2018-07-31
AQR Capital Management LLC 2643274 1.18% -2046074 -43.63% 2018-06-30
Camber Capital Management LLC 2500000 1.12% -- -- 2018-06-30
Citadel Advisors Llc 2056268 0.92% 1386741 207.12% 2018-06-30
BNP Paribas Arbitrage, SA 3293567 1.47% 2761216 518.68% 2018-03-31
Quantitative Management Associates LLC 5583735 2.50% -1510540 -21.29% 2018-03-31
First Quadrant L P 2007365 0.90% -38800 -1.90% 2017-12-31
Bridgewater Associates Inc 2122848 0.95% 150629 7.64% 2017-12-31
NORTH TIDE CAPITAL LLC 4000000 1.79% 1000000 33.33% 2017-09-30
Broadfin Capital, LLC 3011323 1.35% 1764400 141.50% 2017-09-30
PointState Capital LP 3895200 1.74% 3830200 5892.62% 2017-09-30
Point72 Asset Management, L.P. 2309904 1.03% -846496 -26.82% 2017-09-30
Fidelity Management and Research Company 3893835 1.74% -433467 -10.02% 2017-09-30
Capital Research Global Investors 15851727 7.11% -2901952 -15.47% 2016-09-30
OZ Management LLC 1511760 0.68% -10141159 -87.03% 2015-12-31
Ascend Capital LLC 4091441 1.84% 4091441 -- 2016-09-30
Security Investors, LLC 3210728 1.45% 131727 4.28% 2017-02-08
Wellington Management Company LLP 1977620 0.89% 844561 74.54% 2016-09-30
State Street Global Advisors (Aus) Ltd 2375685 1.07% 145245 6.51% 2016-12-31
Victory Capital Management Inc. 1839804 0.83% 1837189 70255.79% 2016-09-30
The Vanguard Group, Inc. 9067089 4.00% 846140745 -- 1999-11-30
BlackRock Institutional Trust Company, N.A. 12213426 4.00% 1139756914 0.10% 1999-11-30
Janus Capital Management LLC 17712663 4.00% 1652945711 0.10% 1999-11-30
共同基金持股
持有者 持有份额 持股比例 份额变化 变化率 报告日期
Worldwide Healthcare 2254100 1.00% -- -- 2019-04-30
iShares S&P Small-Cap 600 Growth ETF 2911636 1.29% -- -- 2019-07-30
Vanguard Strategic Equity Fund 3044997 1.35% 1446662 90.51% 2019-03-31
Vanguard Small Cap Value Index Fund 3213478 1.42% -117674 -3.53% 2019-06-30
iShares Russell 2000 ETF 4905184 2.17% 9603 0.20% 2019-07-30
Vanguard Small Cap Index 5228131 2.31% -27257 -0.52% 2019-06-30
Vanguard Total Stock Market Index Fund 5713130 2.52% 1296 0.02% 2019-06-30
Miller Opportunity Trust 6400000 2.83% 400000 6.67% 2019-06-30
iShares Core S&P Small-Cap ETF 12152112 5.37% 11682 0.10% 2019-07-30
Columbia Small Cap Index Fund 1082830 0.48% -11330 -1.04% 2019-06-30
Vanguard Extended Market Index Fund 2771040 1.22% 3526 0.13% 2019-06-30
SPDR 1330957 0.59% 62290 4.91% 2019-07-31
iShares Nasdaq Biotechnology ETF 2232759 0.99% 19086 0.86% 2019-07-30
Invesco Dynamic Pharmaceuticals ETF 2053529 0.91% -- -- 2019-07-31
iShares Russell 2000 Value ETF 1950304 0.86% 31996 1.67% 2019-07-31
Vanguard Explorer Fund 1451365 0.64% 547689 60.61% 2019-03-31
Invesco S&P SmallCap Health Care ETF 1084410 0.48% -25820 -2.33% 2019-07-31
Principal SmallCap S&P 600 Idx SP 1267944 0.56% 7506 0.60% 2019-06-30
Primo Miller Opportunity Fund 1244000 0.55% 72800 6.22% 2019-07-31
Vanguard Strategic Small Cap Equity Fund 1086645 0.48% 261067 31.62% 2019-03-31
Vanguard Tax Managed Small Cap Fund 1786682 0.79% 14600 0.82% 2019-05-31
iShares Core S&P US Total Market ETF 11999593 5.31% -- -- 2019-05-30
iShares Core MSCI AllCntry Wld exCan ETF 11999593 5.31% -- -- 2019-05-30
iShares US Small Cap ETF (CAD-Hedged) 4560532 2.02% -7659 -0.17% 2019-05-30
Vanguard Small Cap Index Fund 5276865 2.33% 43947 0.84% 2019-04-30
DFA US Small Cap Portfolio 1087552 0.48% -419341 -27.83% 2019-03-31
Vanguard Market Neutral Fund 1017427 0.45% 642803 171.59% 2018-12-31
DFA US Targeted Value Portfolio 1049110 0.47% -- -- 2019-01-31
iShares S&P Mid-Cap 400 Value ETF 1388034 0.62% 1878 0.14% 2018-06-14
Fidelity 900074 0.40% -- -- 2018-12-31
TIAA-CREF Quant Small-Cap Equity Fund 1004600 0.45% -- -- 2018-10-31
iShares S&P Small-Cap 600 Value ETF 3055408 1.36% -10095 -0.33% 2018-11-30
EdRF US Value 950000 0.42% -50000 -5.00% 2018-09-30
TIAA-CREF Small-Cap Equity Instl 991600 0.44% 991600 -- 2018-07-31
CREF Stock R1 1001457 0.45% -9856 -0.97% 2018-07-31
Columbia Small Cap Index Z 1110700 0.50% 12910 1.18% 2018-07-31
DFA US Targeted Value I 1114141 0.50% -134495 -10.77% 2018-07-31
PowerShares Dynamic Pharmaceuticals ETF 954538 0.40% -- -- 2018-09-13
DFA US Small Cap Value II 1413246 0.63% -197476 -12.26% 2018-07-31
DFA US Small Cap I 1647697 0.74% -259674 -13.61% 2018-07-31
Vanguard Tax-Managed Small Cap Adm 1703082 0.76% 508800 42.60% 2018-07-31
iShares Russell 2000 Value 1963942 0.83% -- -- 2018-09-12
Vanguard Extended Market Idx Inv 2663023 1.19% 46 -- 2018-07-31
Vanguard Small Cap Value Index Inv 3181469 1.42% 34986 1.11% 2018-07-31
PowerShares S&P SmallCap Health Care ETF 2549417 1.07% 53392 2.14% 2018-09-13
iShares Nasdaq Biotechnology 2539333 1.07% -4833 -0.19% 2018-09-12
iShares S&P Small-Cap 600 Value 3247594 1.37% 3922 0.12% 2018-09-12
Legg Mason Opportunity C 6500000 2.90% -- -- 2018-06-30
Vanguard Total Stock Mkt Idx 5070937 2.26% 54296 1.08% 2018-07-31
iShares US Pharmaceuticals 746384 0.32% -- -- 2018-09-06
Fidelity Spartan 917087 0.41% 28293 3.18% 2018-07-31
JPMorgan US Small Company Instl 816100 0.36% -253700 -23.71% 2018-07-31
Schwab US Small-Cap ETF 552043 0.32% -- -- 2018-07-26
State Street Russell Small/Mid Cap Idx Fd Cl I 721700 0.32% 44800 6.62% 2017-06-30
Fidelity VIP Mid Cap Inv 1045000 0.47% -- -- 2018-05-31
AST Prudential Growth Allocation Port 1413500 0.63% -1989000 -58.46% 2018-04-30
iShares Russell 1000 Value 718187 0.47% 226 0.03% 2018-06-21
iShares Russell Mid-Cap Value 680588 0.45% -- -- 2018-06-21
iShares S&P Mid-Cap 400 Value 1388034 0.88% 1878 0.14% 2018-06-14
Tekla Healthcare Investors 637200 0.29% -- -- 2017-12-31
Deutsche Core Equity S 783099 0.35% -- -- 2018-04-30
DFA US Core Equity 2 I 736854 0.33% -- -- 2018-03-31
Principal MidCap S&P 400 Index SP 666695 0.30% 5641 0.85% 2017-12-31
Invesco Global Health Care A 792803 0.36% -- -- 2017-09-30
AQR Multi-Strategy Alternative I 648027 0.29% 648027 -- 2017-09-30
VA CollegeAmerica Amcap 529F 11483300 5.15% -- -- 2016-12-31
Vanguard 500 Index Inv 2899645 1.30% 84335 3.00% 2016-12-31
Vanguard Institutional Index I 2166039 0.97% -23999 -1.10% 2016-12-31
Guggenheim S&P 500 1597480 0.72% -- -- 2017-02-08
Fidelity Advisor 1004900 0.45% -80900 -7.45% 2016-12-31
VA CollegeAmerica New Economy 529F 848800 0.38% -- -- 2016-12-31
VA CollegeAmerica Grth Fund of Amer 529F 2548134 1.14% -180000 -6.60% 2016-12-31
Vanguard 500 Index Fund 2484592 1.10% 15359 0.60% 2015-10-31
VA CollegeAmerica Small Cap World 2672381 1.20% -140937 -5.00% 2015-09-30
VA CollegeAmerica AMCAP 2837798 1.20% -- -- 2015-09-30
Janus Contrarian Fund 4203059 1.90% -976 -- 2015-09-30
Vanguard Mid-Cap Index Fund 4308876 1.90% 20561 0.50% 2015-10-31
Janus Fund 2386473 1.10% -- -- 2015-09-30
Goldman Sachs Mid Cap Value Fund 2280135 1.00% 154252 7.30% 2015-09-30
Vanguard Institutional Index Fund 2238161 1.00% 8859 0.40% 2015-10-31
Prudential Jennison Mid Cap Growth 2111316 0.90% -- -- 2015-10-31
SPDR® S&P 500® ETF Trust 2052948 0.90% 195076 10.50% 2015-10-31
SPDR® S&P 500 ETF 2044098 0.90% 12272 0.60% 2015-11-27
VA CollegeAmerica Growth Fund of America 8816000 3.90% 143300 1.60% 2015-09-30
Fidelity® Select Health Care Portfolio 2100000 0.90% -300000 -12.50% 2015-10-31

Hermanth Jacob Varghese Dr. Hermanth J. Varghese is Executive VP-Corporate Development & Strategy at Endo International Plc. He is on the Board of Directors at Litha Healthcare Group Ltd. Dr. Varghese was previously employed as an Assistant Vice President by Medical Discovery Management Corp. and an Assistant Vice President by MedTech Partners, Inc. He also served on the board at Trillium Therapeutics, Inc. He received his undergraduate degree from the University of Western Ontario and a doctorate degree from the University of Western Ontario.

量化对比

全部评论 0

  • 暂无评论

阿布量化公众号二维码 abu_quant 扫一扫关注阿布量化

热门推荐